These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15252274)

  • 1. Ziprasidone and weight gain.
    Jaworowski S; Hauser S; Mergui J; Hirsch H
    Clin Neuropharmacol; 2004; 27(2):99-100. PubMed ID: 15252274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ziprasidone augmentation of clozapine in 11 patients.
    Kaye NS
    J Clin Psychiatry; 2003 Feb; 64(2):215-6. PubMed ID: 12633133
    [No Abstract]   [Full Text] [Related]  

  • 3. Weight Gain While Switching from Polypharmacy to Ziprasidone: A Case Report.
    Lee CP; Chen AP; Juang YY
    Clin Schizophr Relat Psychoses; 2015; 9(3):141-4. PubMed ID: 23644168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight gain--as possible predictor of metabolic syndrome.
    Grahovac T; Ružić K; Dadić-Hero E; Sepić-Grahovac D; Sabljić V
    Psychiatr Danub; 2011 Mar; 23(1):105-7. PubMed ID: 21448110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
    Kostulski A; Wyszogrodzka-Kucharska A; Rabe-Jabłońska J
    Przegl Lek; 2005; 62(9):938-43. PubMed ID: 16541734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis.
    Pérez-Iglesias R; Ortiz-Garcia de la Foz V; Martínez García O; Amado JA; Garcia-Unzueta MT; Ayesa-Arriola R; Suarez-Pinilla P; Tabares-Seisdedos R; Crespo-Facorro B
    Schizophr Res; 2014 Oct; 159(1):90-4. PubMed ID: 25151200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ziprasidone induced symptomatic bradycardia: a case report.
    Menon V; Kattimani S; Ayyanar S
    Aust N Z J Psychiatry; 2011 Sep; 45(9):789. PubMed ID: 21668298
    [No Abstract]   [Full Text] [Related]  

  • 8. Ziprasidone: profile on safety.
    Goodnick PJ
    Expert Opin Pharmacother; 2001 Oct; 2(10):1655-62. PubMed ID: 11825308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ziprasidone-induced tardive dyskinesia.
    Mendhekar DN
    Can J Psychiatry; 2005 Aug; 50(9):567-8. PubMed ID: 16262114
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of ziprasidone-induced mania and the role of 5-HT2A in mood changes induced by atypical antipsychotics.
    Lu BY; Lundgren R; Escalona PR; Roberts BB
    J Clin Psychiatry; 2002 Dec; 63(12):1185-6. PubMed ID: 12530423
    [No Abstract]   [Full Text] [Related]  

  • 11. A Case of Sleepwalking With Sleep-Related Eating Associated With Ziprasidone Therapy in a Patient With Schizoaffective Disorder.
    Das P
    J Clin Psychopharmacol; 2016 Aug; 36(4):393-4. PubMed ID: 27281388
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrocardiographic changes with ziprasidone.
    Loebel A; Miceli J; Chappell P; Siu C
    J Am Acad Child Adolesc Psychiatry; 2006 Jun; 45(6):636-637. PubMed ID: 16721311
    [No Abstract]   [Full Text] [Related]  

  • 13. Antipsychotic-induced weight gain: a comprehensive research synthesis.
    Allison DB; Mentore JL; Heo M; Chandler LP; Cappelleri JC; Infante MC; Weiden PJ
    Am J Psychiatry; 1999 Nov; 156(11):1686-96. PubMed ID: 10553730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of ziprasidone associated with acutely worsened diabetes mellitus.
    Honigberg MC; Bui MP; Coconcea C
    Psychosomatics; 2013; 54(3):304-5. PubMed ID: 23680062
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypomanic episodes after receiving ziprasidone: an unintended "on-off-on" course of treatment.
    Brieger P
    J Clin Psychiatry; 2004 Jan; 65(1):132-5. PubMed ID: 14744182
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation induced by high-dose ziprasidone: a case report.
    Kaushik S; Maccabee N; Kaushik S; Lindenmayer JP
    J Clin Psychiatry; 2009 Sep; 70(9):1326-7. PubMed ID: 19818257
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary retention associated with ziprasidone: a case report.
    Mago R; Chism LM; Pinninti NR; Certa K
    J Clin Psychiatry; 2008 Mar; 69(3):499-500. PubMed ID: 18402503
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute pisa syndrome and pharnygolaryngeal dystonia due to ziprasidone.
    Duggal HS
    J Neuropsychiatry Clin Neurosci; 2008; 20(1):108-9. PubMed ID: 18305296
    [No Abstract]   [Full Text] [Related]  

  • 19. Ziprasidone and migraine headache.
    Boeker T
    Am J Psychiatry; 2002 Aug; 159(8):1435-6. PubMed ID: 12153843
    [No Abstract]   [Full Text] [Related]  

  • 20. Ziprasidone, a new atypical antipsychotic drug.
    Carnahan RM; Lund BC; Perry PJ
    Pharmacotherapy; 2001 Jun; 21(6):717-30. PubMed ID: 11401184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.